CEO Today USA Awards

MISSOURI www.ceotodaymagazine.com 74 CEO Today USAAwards 2017 Curium – the leader in nuclear medicine with a respected heritage Curium is the world’s largest global nuclear medicine company, formed through the union in January 2017 of IBA Molecular and Mallinckrodt Nuclear Medicine LLC, two well-respected names in nuclear imaging. Together, we have been dedicated to serving the nuclear medicine industry since the 1960s, and this long and proven heritage provides the catalyst for our future growth opportunities. Paying tribute to the pioneering spirit and radiation research performed by Marie and Pierre Curie, our name, Curium, also highlights the company’s focus on nuclear medicine, as we invest our efforts towards the growth of the nuclear medicine industry and its role in global healthcare. Drawing from more than 100 years of combined experience, Curium specializes in the development, manufacture and distribution of radioactive tracers, which are used in molecular imaging and therapy to diagnose and treat diseases earlier and more accurately, including cancer, and heart, brain, and bone diseases. This helps to make medical treatment more effective, improving outcomes for patients and reducing the long-term cost of care. Diverse product portfolio with a global reach With our corporate office in Paris, France, Curium’s diverse portfolio of more than 50 radiopharmaceutical products is supplied to more than 6,000 hospitals and medical facilities, serving customers in 60 countries across the globe. Curium’s 1,600-strong employee base work tenaciously to ensure that our potentially life-saving products are brought to approximately 35,000 patients every day who are in need of crucial diagnosis and treatment, reaching nearly 14 million patients a year. It’s all part of our commitment to give our clients superior solutions. We pride ourselves on being able to supply products that are best in class and second to none, and we are committed to the development and launch of new diagnostic and therapeutic solutions. Our vertically integrated radiopharmaceutical manufacturing networks are the largest the industry has to offer. They include: • a molybdenum processing facility • three large single-photon emission computed tomography (SPECT) facilities • 20 SPECT and 17 positron emission tomography (PET) radiopharmacies. Curium’s main production facilities are strategically located in Saclay, RENAUD A. DEHARENG CEO of Curium FIRM PROFILE Renaud A. Dehareng is Chief Executive Officer of Curium, the world’s largest global nuclear medicine company, helping more than 35,000 patients every day and with activities in more than 60 countries. Since becoming CEO in 2012, he has focused on developing Curium from a small European loss-making company into a successful global leader in nuclear medicine. He is now leveraging Curium’s unique global infrastructure to serve its nuclear medicine clients with an emphasis on compliance, service reliability, operational excellence, and new product development. Mr. Dehareng has made Curium a bigger, global, and vertically integrated institution. He is leading Curium in its next stage of development, utilizing its unique size, global assets, and experience to develop new nuclear medicine diagnostic and therapeutic solutions. Mr. Dehareng’s main achievement has been to pull together the best team of 1,600+ members worldwide to take Curium through its vision and strategy. Mr. Dehareng has been part of Curium and its predecessor companies since 2009. Prior to his current role, he was group COO and CEO of Europe. Previously Mr. Dehareng served in Arthur Andersen’s strategic consulting division. He joined Arthur Andersen after his graduation from Warwick Business School in the UK. Mr. Dehareng is Belgian and lives in Washington, DC with his wife and three children. In his spare time he competes in triathlons and enjoys kite surfing. ABOUT RENAUD A. DEHARENG CONTACT Curium Global Headquarters 63, avenue des Champs-Elysées, 75008 Paris, France Telephone: +33 1 69 85 70 70 contactus@curiumpharma.com Curium North American Headquarters 111 Westport Plaza, Suite 800, St Louis, MO 63146, USA Tel: +1 888 744 1414 NuclearMedicine@curiumpharma.com